Optimization of drug therapy for benign prostatic hyperplasia
The article is devoted to research of medical treatment benign prostatic hyperplasia (BPH). The clinical and morphological study showed that treatment with alpha-blockers BHP is most effective to eliminate the symptoms of lower urinary tract. The therapy BHP 5alpha-reductase inhibitors effective in patients with moderate to severe symptoms of lower urinary tract. The phytotherapy BPH in patients with minor symptoms and in the prevention of disease.